Here is a brief preview of this blast: On Monday, August 1, Gracell announced (press release) the appointment of Wendy Li as Chief Medical Officer (CMO). Below, Celltelligence provides insights on how Gracell could leverage Li's vast experience in the CAR-T field.
About The Author
The Celltelligence Team
Content Leads & Contributors
The Celltelligence team has combined experience in oncology, including cell therapy, CAR-T, immunology, microbiology, biochemistry, and other various fields in life sciences. Our team members include PhDs, industry veterans, and analysts tuned to The Street – all of whom help to create a more actionable service of delivering cell therapy intelligence.